Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia
Fujii, Y.
Seishin Shinkeigaku Zasshi 103(12): 1030-1035
2001
ISSN/ISBN: 0033-2658 PMID: 11925840 Document Number: 533351
Document emailed within 1 workday
Related Documents
Dahn, G.; Kothe, K. 1990: Drug therapy under physical conditioning and during phase IIi rehabilitation in patients following acute myocardial infarct Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(14): 411-413Thakore, J.H.; Mann, J.N.; Vlahos, I.; Martin, A.; Reznek, R. 2002: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 26(1): 137-141
Ishihara, H. 2011: Treatment for exacerbation--drug and non-drug therapy, criteria of hospitalization and ICU admission Nihon Rinsho. Japanese Journal of Clinical Medicine 69(10): 1863-1868
Weidle, P.J.; Malamba, S.; Mwebaze, R.; Sozi, C.; Rukundo, G.; Downing, R.; Hanson, D.; Ochola, D.; Mugyenyi, P.; Mermin, J.; Samb, B.; Lackritz, E. 2002: Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance Lancet 360(9326): 34-40
Jackson, J.E.; Tally, J.D.; Ellis, W.Y.; Mebrahtu, Y.B.; Lawyer, P.G.; Were, J.B.; Reed, S.G.; Panisko, D.M.; Limmer, B.L. 1990: Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy American Journal of Tropical Medicine and Hygiene 43(5): 464-480
Omori, T. 2011: Drug therapy of schizophrenia with cognitive function and QOL taken into consideration Seishin Shinkeigaku Zasshi 113(1): 111-116
Holcenberg, J.S.; Halpern, L.M. 1970: Drug therapy. II. Treatment of drug misuse Northwest Medicine 69(1): 31-33
Miyamoto, M. 2006: Trends in multi-high-dose drug therapy for schizophrenia in Japan Seishin Shinkeigaku Zasshi 108(6): 599-607
Isoniemi, H.; Eklund, B.; Höckerstedt, K.; Korsbäck, C.; Salmela, K.; von Willebrand, E.; Häyry, P.; Ahonen, J. 1990: Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results Transplantation Proceedings 22(4): 1365-1366
Ono, H. 2001: Cognitive therapy combined with drug therapy for the treatment of patients with depressive disorder Seishin Shinkeigaku Zasshi 103(12): 1036-1040
Aghokeng, A.F.; Kouanfack, C.; Laurent, C.; Ebong, E.; Atem-Tambe, A.; Butel, C.; Montavon, C.; Mpoudi-Ngole, E.; Delaporte, E.; Peeters, M. 2011: Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients Aids 25(17): 2183-2188
Davis, J.M.; Andriukaitis, S. 1986: The natural course of schizophrenia and effective maintenance drug treatment Journal of Clinical Psychopharmacology 6(1 Suppl): 2s
Welbel, L. 1980: Difficulties of evaluation of the results of drug treatment of schizophrenia Psychiatria Polska 14(1): 51-57
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Tarazi, F.I.; Shahid, M. 2009: Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania Drugs of Today 45(12): 865-876
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Pickart, L. 1981: Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate) International Journal of Tissue Reactions 3(2): 65-72
Chang, T.M.; Coffey, J.F.; Barré, P.; Gonda, A.; Dirks, J.H.; Levy, M.; Lister, C. 1973: Microcapsule artificial kidney: treatment of patients with acute drug intoxication Canadian Medical Association Journal 108(4): 429-433
Kato, J.; Eto, T. 2006: Should drug treatment be started with monotherapy or combination therapy for patients with hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 6): 254-257
Shmyrev, V.I.; Kryzhanovskiĭ, S.M. 2008: The domestic drug cereton in the treatment of patients in the acute period of ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(12): 53-56